Cart
sales@molnova.com
BPH-1358
CAS No. 5352-53-4
BPH-1358 ( NSC50460 )
Catalog No. M24517 CAS No. 5352-53-4
BPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 612 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1233 | In Stock |
|
| 500MG | 2457 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBPH-1358
-
NoteResearch use only, not for human use.
-
Brief DescriptionBPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor.
-
DescriptionBPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor. With IC50s of 1.8 μM and 110 nM, respectively. And it is active against S. aureus in vitro (MIC ~250 ng/mL).
-
SynonymsNSC50460
-
PathwayOthers
-
TargetOther Targets
-
Recptorhuman bisphosphonate farnesyl diphosphate synthase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5352-53-4
-
Formula Weight601.5
-
Molecular FormulaC32H30Cl2N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC=C(C2=CC=C(C(NC3=CC=CC(C4=NCCN4)=C3)=O)C=C2)C=C1)NC5=CC=CC(C6=NCCN6)=C5.[H]Cl.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhu W, et al. Antibacterial drug leads: DNA and enzyme multitargeting. J Med Chem. 2015 Feb 12;58(3):1215-27.
molnova catalog
related products
-
CTPI-2
CTPI-2 is an inhibitor of mitochondrial citrate carrier SLC25A1 with(KD : 3.5 μM).?CTPI-2 inhibits glycolysis, PPARγ, and its downstream target the glucose transporter GLUT4.?
-
3-epi-Isocucurbitaci...
3-epi-Isocucurbitacin B.
-
Brr2 Inhibitor C9
Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
